Members matter ...
Octapharma USA: FDA Grants Orphan Drug Exclusivity to wilate®, the First VWF Concentrate for Prophylaxis in All Types of VWD
PARAMUS, NJ. 29/04/2024. PRESS RELEASE Octapharma USA, Inc. announced the U.S. Food and Drug Administration (FDA) has granted orphan drug exclusivity for wilate®, von Willebrand Factor/Coagulation Factor VIII Complex (Human) Lyophilized Powder for Solution for Intravenous Injection, for routine prophylaxis
Takeda Announces Global Discontinuation of HEMOFIL® M and RECOMBINATE®
Important Community Notice from the Hemophilia Foundation of Maryland Takeda Announces Global Discontinuation of HEMOFIL® M and RECOMBINATE® Takeda has announced its decision to globally discontinue HEMOFIL® M [Antihemophilic Factor (Human), Method M, Monoclonal Purified] and RECOMBINATE® [Antihemophilic Factor (Recombinant)]. Takeda recognizes the significant
On the forefront of advocacy & support
The Hemophilia Foundation of Maryland (HFM) is a Nonprofit Organization, which devotes its efforts to improving the quality of life for persons affected with bleeding disorders and their complications. This mission is accomplished through outreach development, educational programs, informational literature, support services and patient referrals. HFM is a proud member of the Hemophilia Federation of America.
Learn who we serve: CLICK HERE
Our community consists of bleeding disorders such as hemophilia A and B, vonWillebrand disorder and platelet disorders.
The Hemophilia Foundation of Maryland is a 501(c)(3) organization and contributions are tax-detuctible.
The Hemophilia Foundation of Maryland (HFM) is a Nonprofit Organization, which devotes its efforts to improving the quality of life for persons affected with bleeding disorders and their complications. This mission is accomplished through outreach development, educational programs, informational literature, support services and patient referrals. HFM is a proud member of the Hemophilia Federation of America.
Our community consists of bleeding disorders such as hemophilia A and B, vonWillebrand disorder and platelet disorders.
The Hemophilia Foundation of Maryland is a 501(c)(3) organization and contributions are tax-detuctible.
The Goals of HFM
- To find a cure for bleeding disorders
- To find funding to support expanded research efforts
- To assist persons with hemophilia and/or related bleeding disorders within the state of Maryland and surrounding areas
- To advocate for a safe and adequate blood supply for all
- To educate the public about hemophilia as well as other bleeding disorders and related problems
- To provide crucial information to our membership, patients, families and medical professionals
- To provide opportunities for children with bleeding disorders to attend a camp that is dedicated to bleeding disorders
- To help provide comprehensive care and treatment for patients with bleeding disorders in coordination with our local hemophilia treatment centers
